Melatonin Protects on Toxicity by Acetaminophen But Not on Pharmacological Effects in Mice
Briefly, the liver of a mouse was perfused for 5 min with prewarmed (37°C) Ca 2ϩ -and Mg 2ϩ -free Hank's balanced salt solution, pH 7.2, containing 10 mM HEPES, 0.5 mM EGTA, and 4.0 mM NaHCO 3 . This was followed by a 15 min perfusion with prewarmed (37°C) Hank's balanced salt solution, pH 7.5, containing collagenase (0.05%) and buffered with 10 mM HEPES and 4.0 mM NaHCO 3 . After the second step of perfusion, isolated cells were centrifuged (50ϫg for 1 min, 4 spins) in minimum essential medium (MEM) to remove nonparenchymatous and dead cells. Then the medium was changed to Williams' E medium (WE) containing 5% fetal bovine serum, 10 Ϫ7 M insulin, 10 Ϫ7 M dexamethasone, 100 units/ml penicillin and 100 mg/ml streptomycin. This procedure routinely yielded over 90% viability based on the trypan blue exclusion test. Approximately 1ϫ10 6 /ml parenchymatous cells were plated on 35-mm Falcon collagen-coated type I dishes. After incubation at 37°C for 2 h in a humidified environment of 5% CO 2 -95% air, the cultures were rinsed with warmed phosphate-buffered saline (PBS) to remove free cells and debris, and then serum-free WE containing 0.12 mg/ml aprotinin was added and the cells were incubated with AA and MLT or NAC.
Cell Viability Cell viability was evaluated by measuring the level of 3 H-thymidine incorporation or using a modification of the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. 20) Briefly, 3 H-thymidine at a final concentration of 0.05 mCi/ml was added to cultured hepatocytes 30 min before the measurement time points. The cultured hepatocytes were washed with PBS two times, and then the cells were harvested from the dishes with a cell scraper. Samples were emulsified in scintillation fluid and measured in a Beckman LS 6000TA beta scintillation counter.
3 Hthymidine incorporation (%) was calculated according to {cpm (test groups)/cpm (control groups)}ϫ100. For MTT assay, following exposure of hepatocytes to AA and MLT or NAC, 50 ml of MTT (10 mg/ml saline) was added, and samples were incubated for 1 h at 37°C. The cells were lysed and solubilized by addition of 500 ml of dimethyl sulfoxide (DMSO) for 2 h at 37°C, and the absorbance of 100-ml aliquots was determined at 590 nm using an Inter-med model NJ-2300 Microplate Reader. Cell viability (%) was calculated relative to the control.
Generation of Reactive Oxygen Species (ROS)
The generation of intracellular reactive oxygen species (ROS) was evaluated based on the intracellular peroxide-dependent oxidation of 2Ј,7Ј-dichlorodihydrofluorescein diacetate (DCFH-DA) to form the fluorescent compound, 2Ј,7Ј-dichlorofluorescein (DCF), as previously described by us. 21) After the treatment with drugs, the cells were incubated with 20 mM DCFH-DA (from a stock solution of 4 mM DCFH-DA in ethanol) at 37°C for 10 min. The culture medium was removed, the cells were washed with PBS, and 2 ml of PBS was added to each well. The fluorescence intensity of the cell suspension was determined using a fluorescence spectrophotometer (RF-1500, Shimadzu, Kyoto, Japan) with excitation at 488 nm and emission at 525 nm. The untreated groups were used as the control. The results are expressed as a percentage of the fluorescence intensity with respect to the control.
Lipid Peroxidation
The lipid peroxide level was assayed by fluorimetrically measuring the level of malondialdehyde (MDA) in hepatocytes using the method of Yagi. 22) Cells were exposed to drugs, and then washed with PBS, scraped and homogenized in ice-cold 1.15% KCl. Samples containing 20 ml of cell lysate were combined with 20 ml of 8.1% sodium dodecyl sulfate (SDS), 150 ml of 20% acetic acid adjusted to pH 3.5, and 150 ml of 0.8% thiobarbituric acid (TBA). The mixture was heated at 95°C for 60 min. After cooling to room temperature, 100 ml of distilled water and 2.0 ml of a mixture of n-butanol and pyridine (15 : 1, v/v) were added to each sample and the mixture shaken was vigorously. After centrifugation at 1200 rpm for 10 min, the supernatant was isolated. The fluorescence intensity was measured using the RF-1500 (Shimadzu) with excitation at 515 nm and emission at 553 nm. A MDA solution made freshly by the hydrolysis of 1,1,3,3-tetraethoxypropane (TEP) was used as the standard. The results are expressed as nmol MDA/mg protein.
Hepatotoxicity and Mortality in Vivo The Effect of MLT on the hepatotoxicity of AA in vivo was estimated by measuring levels of serum glutamyl oxaloacetic transaminase (GOT) and glutamyl pyruvic transaminase (GPT) activity. These activities were monitored with a commercial kit from Wako Pure Chemical Industries (Osaka, Japan). Acute mortality was recorded for 72 h after the intraperitoneal (i.p.) injection of AA.
Temperature Measurement A rectal probe for mice and a thermocouple-monitoring thermometer were obtained from Natume Industries (Tokyo, Japan). The probe was inserted into the rectum to a depth of 2 cm. All experiments began with the i.p. administration of AA at 10 am, and temperature measurements were made 1 h thereafter.
Nociceptive Assessment Mice were assessed for nociceptive sensitivity using the writhing test as described by Koster et al. 23) All mice were acclimatized to the procedure room for at least 1 h prior to testing. All testing occurred near midphotoperiod (10:00-16:00). Mice were placed on a glass surface within transparent Plexiglas cylinders and allowed 30 min to habituate to the cylinder. At this point, the mice were weighed, injected with drugs or vehicle, and then placed back into the cylinder. Thirty minutes later, 0.9% acetic acid in saline was injected i.p. (10 ml/kg). Mice were placed in the cylinders once again and observed continuously for 30 min. Stereotypical writhes (lengthwise constrictions of the torso with a concomitant concave arching of the back) were counted over this period in 5-min bins. Four mice were observed and scored at a time. In all cases, the experimenter was kept blind to the drug/vehicle solutions. Antinociception was quantified by reference to the vehicle-treated control group.
Statistical Analysis Statistical analysis of the results was performed with a one-way analysis of variance (ANOVA) followed by Scheffe's F test. A p-value of less than 0.05 was considered significant.
RESULTS AND DISCUSSION
Cell Viability First, we examined the effect of melatonin (MLT) on the acetaminophen (AA)-induced loss of cell viability in mouse primary cultured hepatocytes (Fig. 1A) . MLT (100 mM) and AA (7 mM) were administered simultaneously to the hepatocytes. The concentration of AA (7 mM) used in the experiments was reported to reduce cell viability in our previous study. 21) As shown in Fig. 1A , MLT had a significant protective effect on cell viability from 12 h in the 3 Hthymidine incorporation assay and MTT assay. MLT alone at more than 5 mM caused a reduction in viability (data not shown). We also examined the dose-dependent effect of MLT on the AA-induced loss of cell viability in the hepatocytes (Fig. 1B) . A typical antioxidant, N-acetyl-L-cysteine (NAC) is a cysteine precursor known to scavenge free radicals and replenish tissue glutathione (GSH) levels. Treatment of humans and animals with NAC ameliorates the hepatotoxicity of AA. 24, 25) Based on these reports, we used NAC as a positive control in this experiment. The AA-induced decline in cell viability was dose-dependently reduced by NAC and MLT. Interestingly, MLT had a protective effect at a lower dose than NAC. MLT is lipophil product than NAC. It is possible to effect of cellular uptake of NAC and MLT depend on their difference of lipophilia. MLT was reported to stimulate the activities of several antioxidant enzymes including superoxide dismutase (SOD) and glutathione peroxidase (GSHPx) in hepatocytes. 26) Transgenic mice over-expressing SOD or GSH-Px are protected from the hepatotoxicity of AA. 27) This may be due to the greater efficacy of MLT in scavenging free radicals and also its ability to stimulate antioxidant enzymes, which is not observed with NAC.
Generation of Reactive Oxygen Species (ROS) and Lipid Peroxidation A significant amount of evidence points to the potential involvement of oxidative stress in the toxicity of AA. We attempted to confirm the effect of MLT (0.1, 1, 10 or 100 mM) on the AA (7 mM)-induced generation of reactive oxygen species (ROS) and lipid peroxidation (Figs. 2A, B) . The AA-induced generation of ROS peaked at 6 h ( Fig. 2A) , followed by a maximal increase in lipid peroxidation at 12 h (Fig. 2B) . These results suggest that after exposure to AA, hepatocytes undergo a sequence of events, an increase in the generation of ROS, followed by lipid peroxidation, and ultimately a loss of cell viability. MLT dose-dependently attenuated the increase in both the generation of ROS and lipid peroxidation by AA. When the co-incubation with 100 mM MLT, it reduced the ROS and lipid peroxidation until near the levels of control. Cuzzocrea and Reiter suggested that MLT is a better antioxidant against lipid peroxidation than vitamins. 6 ) Thus MLT has a potential antioxidative effect on the AA-induced generation of reactive oxygen species (ROS) and lipid peroxidation. Figs. 1 and 2 , the AA-induced loss of cell viability, generation of ROS, and increase in lipid peroxidation were significantly abolished by MLT in mouse primary cultured hepatocytes. Next, we examined in vivo the effect of MLT (10 mg/kg, subcutaneously; s.c.) on mortality and hepatotoxicity in AA-treated mice (Figs. 3A, B) . MLT and AA were administered simultaneously. The mortality for AA at 400, 600, or 800 mg/kg (i.p.) alone (nϭ10) was 15Ϯ5, 50Ϯ10, and 80Ϯ10%, respectively (Fig. 3A) . A single treatment with MLT (10 mg/kg, s.c.) has never shown the mortality. Cotreatment with MLT significantly reduced the mortality (AA 400 mg/kg, 0%; AA 600 mg/kg, 20Ϯ5%; AA 800 mg/kg, 55Ϯ5%). The hepatotoxicity of AA was estimated by measuring transaminase activity, such as GPT and GOT, after treatment for 18 h (Fig. 3B) . This was the time point at which the increase in transaminase activity caused by AA peaked in our previous report. 28) AA (400 mg/kg, i.p.) alone remarkably increased levels of GPT (8125Ϯ1923 KU/l) and GOT (8028Ϯ1743 KU/l) activity compared to the control group (33.8Ϯ4.8 and 108Ϯ8.8 KU/l, respectively). MLT (10 mg/kg, s.c.) alone treatment group has no change the control group (GPT, 35.6Ϯ5.2 KU/l; GOT, 107Ϯ11.8 KU/l). We examined the timing of the effect of MLT on the hepatotoxicity of AA. Pretreatment for 3 d, or treatment 2 h before, simultaneously, or 2 h after all significantly ameliorated the AA-induced rise in GPT and GOT activity, 102.8Ϯ24.8 and 142.7Ϯ37.6 KU/l, 82.5Ϯ13.8 and 136.7Ϯ29.4 KU/l, 345.4Ϯ55.8 and 336.5Ϯ 63.4 KU/l, and 944.6Ϯ210.1 and 882.6Ϯ145.3 KU/l, respectively. Pretreatment had a greater effect on the hepatotoxicity of AA than post-treatment. The results suggest that MLT prevents the hepatotoxicity and which does not mean direct action to toxicity caused by AA. The depletion of liver tissue GSH was restored by MLT and/or NAC treatment. 29) Grewal and Racz reported that late treatment with NAC had no effect on the toxicity of AA, 30) however, NAC is used for detoxification in a variety of diseased states including AA toxicity. Pierrefiche et al. suggested that the hepatic metabolite of MLT, 6-hydroxymelatonin sulfate, may also be a free radical scavenger since it was shown to be capable of resisting lipid peroxidation. 31) These results suggest that MLT may act not only to prevent AA toxicity but also as a detoxification medicine.
Mortality and Hepatotoxicity in Vivo As shown in
Pharmacological Effect In general, it is thought that the pharmacological effect is weakened if the toxicity is attenuated. We also examined the effect of MLT on the pharmacological action of AA as an antipyretic effect and antinociception (Figs. 4A, B) . MLT and AA were administered simultaneously. Body temperature in the non-treatment (control) group and MLT (10 mg/kg, s.c.) treatment group was 37.41Ϯ 0.19 and 37.23Ϯ0.14°C, respectively. AA at 25, 50, 100, or 200 mg/kg (i.p.) caused hypothermia, which increased dose-dependently at 36.77Ϯ0.18, 37.51Ϯ0.14, 36.32Ϯ0.19, and 34.82Ϯ0.19°C, respectively (Fig. 4A) AA (Figs. 4A, B) . There are a number of points at which MLT may interfere with the inflammatory process. 6) Prostaglandin (PG) levels in exudates and cyclooxygenase-2 expression in carrageenan-treated rats were found to be completely suppressed by MLT. 32) There was no significant difference in pharmacological action between the control group and MLT alone treatment group, but MLT may potentiate the effects of other antiinflammatory drugs.
We have used MLT at 10 mg/kg for in vivo studies and 100 mM for in vitro studies, which dosage too high as compared with the concentration of MLT under physiological conditions. However, half-life of MLT in the blood is relatively short (20-40 min), tissue levels of MLT remain higher than physiological levels when blood MLT concentration fall after administration of a pharmacological dose of MLT.
33) The mechanisms of MLT action in physiological and pharmacological concentration may be different.
In conclusion, our results suggest that MLT has a potentially useful preventive effect on the toxicity of AA, but no effect on the antipyretic effect and antinociception caused by AA.
